+ All Categories
Home > Documents > Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual...

Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual...

Date post: 18-Dec-2015
Category:
Upload: ross-foster
View: 224 times
Download: 2 times
Share this document with a friend
Popular Tags:
30
Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007
Transcript
Page 1: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Pharmacoeconomic and Outcomes Fellowship

Guidelines

ISPOR and ACCP Joint Statement

ISPOR Annual Meeting

May 22, 2007

Page 2: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Task Force Group Leaders Alan Bakst,Pharm.D., MBA

Senior Director, Health Economics and Reimbursement Baxter International Employer Group Leader

Sandra Kane-Gill, Pharm.D., M.S. Asst. Prof., U. of Pittsburgh School of Pharmacy Educator Group Leader

Prabashni Reddy, Pharm.D., M.S. Director, Clinical Outcomes Research ABT Associates Consulting/Consumer Group Leader

Shiraz Gupta, Pharm.D., M.P.H. Fellow, HEOR-UIC/TAP Pharmacoeconomic Fellowship Survey Manager and Analyst

Page 3: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Program Agenda

Introduction and History of PE Guidelines Preparation of Survey and Survey Method Training Program Requirements, Qualifications

of Training Site, Fellowship Applicant Criteria Fellowship Experience, Evaluation of Fellow,

Preceptor and Program Concluding Remarks and open discussion

Page 4: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Why PEOR Fellowship Guidelines?

Field of pharmacoeconomics and health outcomes research is growing rapidly.

Researchers and consumers of PEOR data require skills to perform PEOR research and interpret results for decision making about adaptation of new health technologies.

Page 5: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Why PEOR Fellowship Guidelines?

Candidates interested in the PEOR field come from multiple disciplines. Providing a recommended framework for core didactic coursework and experiential training may be valuable for people seeking entry to the field.

Page 6: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Why PEOR Fellowship Guidelines?

Organizations and sponsors interested in providing training in PEOR can utilize guidelines to develop their programs

Professional organizations may utilize guidelines to accredit PEOR fellowships

Employers in field can feel comfortable in the expertise provided by person completing a fellowship.

Page 7: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Why PEOR Fellowship Guidelines?

Assists candidates in evaluating and comparing training programs

Page 8: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

History of PEOR Fellowship Guidelines

1999 Am. College of Clinical Pharmacy issues a Position Statement on Guidelines for PE Research Fellowships Pharmacotherapy 1999;19(9):1105-1109

May 1998 ISPOR position statement on Standards for fellowship training in pharmacoeconomics and outcomes research.

Vittorio Maio, Jennifer Lofland, Tammy Girts, David

Nash, and others who have surveyed PE fellowship programs, preceptors and fellows, and described their findings in publications (Am. J. Pharm.Ed. 2003;67 (3) )

Page 9: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Task Force Survey Objectives

1) Understand how current PEOR researchers and consumers of health outcomes information valued PEOR fellowship programs in terms of:

qualifications of the training site, program, and preceptor(s),

fellowship applicant requirements, research commitment, didactic coursework evaluation of fellow’s research skills

2) Develop PEOR fellowship guidelines based on information attained from the survey.

Page 10: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Survey Development Timeline

October 2006 Task Force Leader Group Draft Survey Preparation

November 2006 Discussions of Draft Survey with Working Groups

December 2006 Finalization of Survey and Dissemination via Survey Monkey

January 2007 Reminders sent to Survey Respondents and non-Respondents

mid month Survey Closed at end of month

February 2007 Tabulation and Preparation of Results

March 2007 Manuscript Preparation

Page 11: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Survey Design

Responder Information (organization membership and practice area)

6 Sections, 28 questions Qualifications of the Training Site Qualifications of the Program Qualifications of the Preceptor(s) Requirements of Fellowship Applicants Research Experience Criteria Evaluation of Fellows Research Skills

Page 12: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Survey Availability

Email link to SurveyMonkey.com Open from Dec. 31, 2006 – Jan. 31,

2007 Respondents and non-respondents were

sent 2 reminders: Jan. 15, 2007 Jan. 29, 2007

Page 13: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Survey Respondents

ISPOR Fellowship Task Force ACCP Outcomes and Economics

Practice Research Network (PRN) 280 Total Survey Recipients 117 Total Survey Respondents 42% Response Rate

Page 14: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Analysis of Data

Response frequencies calculated as percentage of total responses per question

Free-text response data incorporated in discussion sections of guidelines

Page 15: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Training Program Requirements

A minimum of 3,000 hours (approximately 75%) of the fellowship training time should be devoted to PEOR research-related activities over a minimum period of two years.

Develop a documented training plan with goals and objectives prior to starting the fellowship.

Page 16: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Training Program Requirements

Availability of advanced educational opportunities in research-related topics.

Ready access to personnel that teach and use research skills.

Have a team of preceptors however fellow assigned one preceptor to be an advisor to oversee the fellow’s training and fellowship experience.

Page 17: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Qualifications of Site

Demonstrate capabilities in performing PEOR through publications, presentation at scientific meetings or through known collaboration with organizations producing PEOR.

Direct or indirect access to healthcare information providing fellow with data to perform PEOR.

Appropriate facilities to conduct research

Page 18: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Qualifications of Site

Administrative support for the preceptor’s research program and the fellowship training program.

Ready access to a medical library or electronic access to medical literature as well as computing facilities.

Access to other sites to provide fellow with experience in multiple practice environments

Page 19: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Preceptor Qualifications

Established and ongoing record of independent research accomplishments and expertise in the area of PEOR through

Fellowship training, a graduate degree and/or equivalent experience

Principal or primary investigator on research grants and/or projects

Published research papers in the peer-reviewed scientific literature on which the preceptor is the primary or senior author

Page 20: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Preceptor Qualifications

Didactic training in research methods and PEOR.

Prior experience training fellows and/or other individuals in PEOR.

Active collaborative research relationship with other health outcomes researchers or organizations.

Page 21: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Fellowship Experience The fellow should demonstrate proficiency in multiple aspects of a PEOR

fellowship through participation in one or multiple studies during their training. These may include:

Literature reviews Dossier development Prospective studies Retrospective studies Economic modeling Patient reported outcomes

The fellow should actively participate in all aspects of research through a combination of didactic and on the job training including:

Study design Study implementation Data collection Data analysis Research program management Reporting

Page 22: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Fellowship Experience The fellow should develop an understanding of multiple aspects of clinical

outcomes through a combination of didactic and on the job training that includes:

Clinical markers (e.g., BP, LDL, glucose) of disease Impact of disease on patients Impact of drug on patients Patient safety (e.g., adverse events) Adherence/Compliance/Persistence Process and delivery of care

The fellow should demonstrate proficiency in multiple aspects of economic outcomes through a combination of didactic and on the job training that includes

Costing Direct medical costs e.g., drug, office visit, hospitalizations, etc. Direct non-medical costs e.g., caregiver costs Indirect costs e.g., loss of work, productivity outcomes (e.g., absenteeism, presenteeism)

Economic analyses e.g., cost-benefit, cost-effectiveness, cost-minimization, or cost-utility

Page 23: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Fellowship Experience The fellow should demonstrate proficiency in multiple aspects of

patient-reported outcomes through a combination of didactic and on the job training that includes:

Health-related quality of life Patient satisfaction Patient preference

The fellow should develop an understanding of multiple aspects of the healthcare delivery system and the implications on PEOR within these systems through a combination of didactic and on the job training that includes:

Healthcare financing Payors/managed care and integrated delivery systems Health technology assessment Clinical practice guideline development and use, Disease management, Medication use policy analysis

Page 24: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Fellowship Experience

The fellow should attain the following grantsmanship skills during the fellowship through a combination of didactic and on the job training that includes:

Identification of sources of funding, Grant and/or proposal development Conception of research ideas Literature retrieval and evaluation Biomedical science ethics Identification of issues related to quality/integrity of HEOR data

The fellow should develop oral communication skills as well as written communication skills, for example through:

Participation in professional and or public communication of PEOR Preparation of reports, abstracts, and manuscripts

The fellow should be encouraged to participate in journal clubs, research workshops and/or seminar series

Page 25: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Evaluation of Fellow, Preceptor and Program

An evaluation of the fellow should ideally occur at 6-month intervals The fellow should be evaluated based on the goals and objectives set at

the beginning of the fellowship. Objective criteria include:

Poster and/or oral presentation at a national meeting Seminar on PEOR related topic Manuscript submission/publication Research project executed in full

Subjective criteria include: Motivation Professionalism Communication skills (verbal, e-mail, formal writing) Presentation skills (research ideas and findings) Collaboration/team work skills Ability to evaluate clinical, economic, and PRO literature Research skills (question development, process, management, analysis, etc) Time management

Page 26: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Evaluation of Fellow, Preceptor and Program In addition, the fellow should perform a preceptor and

program evaluation every six months

The fellow should use the goals and learning objectives developed at the beginning of the fellowship to determine if the program is progressing as planned

This is an optimal time to discuss modification of the goals and objectives incase the fellow has developed additional interests or altered their original interests

It is recommended that the fellow be able to express their assessment of the primary preceptor and contributing preceptors’ abilities to support/accomplish the outlined goals and objectives

Page 27: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Employer Working Group Members

Alan Bakst Baxter International Alexander Chernavin Sanofi-Aventis Zeba Khan Novartis Pharmaceuticals Connie Mclaughlin-Miley Abbott Laboratories Jenny Sung Novartis Pharmaceuticals Shiraz Gupta TAP Pharmaceuticals Concetta Crivera Ortho-McNeil Neurologics Izhar Hussain Abbott Laboratories Tracy Li Bristol-Myers Squibb Liviu Niculescu Pfizer Vanja Sikirica Ortho-McNeil Janssen

Page 28: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Academia Members

Sandra Kane U. of Pittsburgh John Bridges Johns Hopkins U. Johanita Burger North-West University Jeff Guo U. of Cincinnati Medical Jackie Kwong U. of Georgia Jeffrey McCombs USC College of Pharmacy Lisa Prosser Harvard Med School Vittorio Maio Jefferson Medical College Glen Schumock U of Illinois at Chicago Marianne Mccollum U of Colorado Kim Coley U. of Pittsburgh Craig Currie Cardiff University Scott Strassels U of Texas Austin Dennis Raisch VA Coop Studies Program Gonzalo Garcia-Donato U of Castilla-La Mancha

Page 29: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Consulting and Health Outcomes Customers

Prabashni Reddy ABT Associates Ljubica Besker-Ivasovic Clinica S. Anna Healther Campbell VA Cooperative Alex Fu Cleveland Clinic Emma Guitierrez DeMesa European Commision Lisa Mucha Thomson

Medstat Jens Rathemann PAION Deutschland Anita Varghese CMS/DHHS Krista Yokoyama Wellpoint

Pharmacy Vladimir Zah ZRX Outcomes

Res. Michael Iskedjian PharmIdeas John Doyle Analytica Int.

Page 30: Pharmacoeconomic and Outcomes Fellowship Guidelines ISPOR and ACCP Joint Statement ISPOR Annual Meeting May 22, 2007.

Next Steps

Draft PEOR Fellowship Guidelines to be placed on ISPOR website for comments

PEOR Guidelines to be published in Pharmacotherapy and on ISPOR and ACCP Websites


Recommended